Exclusive

Publication

Byline

Location

"India is well positioned to emerge as a major market and a manufacturing hub for monoclonal antibodies"

India, March 31 -- The company has recently secured financing of Rs 648 crore from the Union Bank of India. What are the major plans in utilising these funds? The capital is being deployed across thr... Read More


How India's Life Sciences Boom Is Creating a New Risk Economy

India, March 31 -- India's life sciences story is no longer a "growth narrative" - it is increasingly a risk-architecture narrative. Hyderabad and Bengaluru are scaling R&D platforms. Gujarat, Telanga... Read More


"Healthcare cybersecurity regulations in India are still evolving"

India, March 31 -- What are the major cybersecurity challenges currently facing the healthcare and pharmaceutical sectors? Over the past few years, the healthcare and pharmaceutical industries have b... Read More


Regulatory Misalignment in Pharma: Fix the System, Not the Industry

India, March 30 -- image credit- freepik India's pharmaceutical regulatory framework has long operated through a dual structure, wherein State Food and Drug Administrations (FDAs) are responsible for... Read More